1)International Agency for Research on Cancer Working Group on the evaluation of Carcinogenic Risks to Humans. Helicobacter pylori. In Schistosomes, Liver Flukes, and Helicobacter pylori. IARC, Lyon, pp 170-240, 1994
2)Inoue K. Stratification of gastric cancer risk by H. pylori infection. In Suzuki H, Warren R, Marshall B(eds). Helicobacter pylori. Springer Japan, Tokyo, pp 169-179, 2016
3)Terasawa T, Nishida H, Kato K, et al. Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians:a systematic review and meta-analysis. PLoS One 9:e109783, 2014
4)Mabe K, Inoue K, Kamada T, et al. Endoscopic screening for gastric cancer in Japan:Current status and future perspectives. Dig Endosc 2021.[Epub ahead of print]
5)加藤勝章,笹島雅彦,伊藤公訓,他.E-プレート‘栄研' H. ピロリIIの抗体価陰性高値の取り扱いについて—胃がんリスク層別化のための血清H. pylori抗体価の適正な判定基準とは.日ヘリコバクター会誌 2:64-71, 2017